Liver-specific catalase expression in transgenic mice inhibits NF-κB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate

Carcinogenesis

Volumn 19, Issue 4, 1998, Pages 631-637

  Nilakantan, Vani ^a   Spear, Brett T ^a   Glauert, Howard P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; CATALASE; CIPROFIBRATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIVER ENZYME; PEROXISOME PROLIFERATOR; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; DRUG EFFECT; ENZYME ACTIVITY; GENE OVEREXPRESSION; LABELING INDEX; LIVER CARCINOGENESIS; LIVER WEIGHT; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; CATALASE; CLOFIBRIC ACID; DNA REPLICATION; HYDROGEN PEROXIDE; LIVER; MICE; MICE, TRANSGENIC; MICROBODIES; NF-KAPPA B; TRANSCRIPTION FACTOR AP-1;

EID: 0031843624     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.4.631     Document Type: Article

References (43)

1. Rao,M.S. and Reddy,J.K. (1987) Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis, 8, 631-636.
2. Glauert,H.R., Beer,D., Rao,M.S., Schwarz,M., Xu,Y.D., Goldsworthy,T.L., Coloma,J. and Pilot,H.C. (1986) Induction of altered hepatic foci by administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine. Cancer Rex., 46, 4601-4606.
3. Cattley,R.C. and Popp,J.A. (1989) Differences between the promoting activities of the peroxisome proliferator Wy-14 643 and phenobarbital in rat liver. Cancer Res., 49, 3246-3251.
4. Reddy,J.K. and Lalwani,N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol., 12, 1-58.
5. Moody,D.E., Reddy,J.K., Lake,B.G., Popp,J.A. and Reese,D.H. (1991) Peroxisome proliferation and non-genotoxic Carcinogenesis: commentary on a symposium. Fund. Appl. Toxicol., 16, 233-248.
6. Eacho,P.I. and Feller,D.R. (1991) Hepatic peroxisome proliferation induced by hypolipidemic drugs and other chemicals. In Witiak,D.T., Newman,H.A.I. and Feller,D.R. (eds) Antilipidemic Drugs. Medicinal, Chemical and Biochemical Aspects. Elsevier Science, Amsterdam, pp. 375-426.
7. Ledwith,B.J., Johnson,T.E., Wagner,L.K., Pauly,C.J., Manam.S., Galloway,S.M. and Nichols,W.W. (1996) Growth regulation by peroxisome proliferators: opposing activities in early and late G1. Cancer Res., 56, 3257-3263.
8. Eacho,P.I., Lanier,T.L. and Brodhecker,C.A. (1991) Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of Wy-14 643 to clofibric acid, nafenopin and LY171883. Carcinogenesis, 12, 1557-1561.
9. Chen,H., Huang,C.Y., Wilson,M.W., Lay,L.T., Robertson,L.W., Chow,C.K. and Glauert,H.P. (1994) Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats. Carcinogenesis, 15, 2847-2850.
10. Yeldandi,A.V., Milano,M., Subbarao,V., Reddy,J.K. and Rao,M.S. (1989) Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis. Cancer Lett., 47, 21-27.
11. Marsman,D.S., Cattley,R.C., Conway,J.G. and Popp,J.A. (1988) Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phtnalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14 643) in rats. Cancer Res., 48, 6739-6744.
12. Schulte-Hermann,R., Bursch,W. and Grasl-Kraupp,B. (1995) Active cell death (apoptosis) in liver biology and disease. In Boyer,J.L. and Ockner,R.K. (eds) Progress in Liver Diseases. Saunders, Philadelphia, pp. 1-35.
13. Bayly,A.C., French,N.J., Dive,C. and Roberts,R.A. (1993) Non-genotoxic hepatocarcinogenesis in vitro - the Fao hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis. J. Cell. Sci., 104, 307-315.
14. Bayly,A.C., Roberts,R.A. and Dive,C. (1994) Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J. Cell Biol., 125, 197-203.
15. Roberts,R.A., Soames,A.R., Gill,J.H., James,N.H. and Wheeldon,E.B. (1995) Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis, 16, 1693-1698.
16. Li,Y., Leung,L.K., Glauert,H.P. and Spear,B.T. (1996) Treatment of rats with the peroxisome proliferator ciproribrate results in increased liver NFκB activity. Carcinogenesis, 17, 2305-2309.
17. Schreck,R., Alberman,K. and Baeuerle,P.A. (1992) Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Rad. Res. Commun., 17, 221-237.
18. Verma,I.M., Stevenson,J.K., Schwarz,E.M., Antwerp,D.V. and Miyamoto,S. (1995) Rel/NF-κB/lκB family: intimate tales of association and dissociation. Genes Devel., 9, 2723-2735.
19. Wulczyn,F.G., Krappmann,D. and Scheidereit.C. (1996) The NF-κB/Rel and 1κB gene families: mediators of immune response and inflammation. J. Mol. Med., 74, 749-769.
20. 2 and antioxidants have opposite effects on the activation of NFκB and AP-1 in intact cells: AP-1 as secondary antioxidant-response factor. EMBO J., 12, 2005-2015.
21. 4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology, 22, 1474-1481.
22. Remy,C.K., Mehlen,P., Mirault,M.E. and Arrigo,A.P. (1996) Inhibition of IκB-alpha phosphorylation and degradation and subsequent NF-κB activation by glutathione peroxidase overexpression. J. Cell Biol., 133, 1083-1093.
23. Fitzgerald,M.J., Webber,E.M., Donovan,J.R. and Fausto,N. (1995) Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. Cell Growth Different., 6, 417-427.
24. Beg,A., Sha,W.C., Bronson,R.T., Ghosh,S. and Baltimore,D. (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature, 376, 167-170.
25. Angel,P. and Karin,M. (1991) The role of jun, fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072, 129-157.
26. Hu,E., Mueller,E., Oliviero,S., Papaioannou,V.E., Johnson,R. and Spiegelman,B.M. (1994) Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J., 13, 3094-3103.
27. Amstad,P.A., Krupitza,G. and Cerutti,P.A. (1992) Mechanism of c-fos induction by active oxygen. Cancer Res., 52, 3952-3960.
28. Abate,C., Patel.L., Rauscher,F and Curran,T (1990) Redox regulation of fos and jun DNA binding activity in vitro. Science, 248, 189-194.
29. Nilakantan,V., Li. Y., Glauert,H.P. and Spear,B.T. (1996) Increased liverspecific catalase activity in transgenic mice. DNA Cell Biol., 15, 625-630.
30. Poosch,M.S. and Yamazaki,R.K. (1986) Determination of peroxisomal fatty acyl-CoA oxidase activity using a lauroyl-CoA-based fluorometric assay. Biochim. Biophys. Acta, 884, 585-593.
31. Beers,R.F. and Sizer,J.W. (1952) A spectrophotometric method of measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem., 195, 133-140.
32. Goldsworthy,T.L., Morgan,K., Popp,J. and Butterworth,B. (1989) Measurement of Chemically-Induced Cell Proliferation in Specific Rodent Target Organs: Technical Notes for the CIIT Workshtop on Cell Replication. Chemical Industry Institute of Toxicology, Research Triangle Park, NC.
33. Deryckere,F. and Gannon,F. (1994) A one-hour minipreparation technique for extraction of DN A-binding proteins from animal tissues. Biotechniques, 16(3), 405.
34. Ledwith,B.J., Johnson,T.E., Wagner,L.K., Pauley,C.J., Manam,S., Galloway,S.M. and Nichols,W.W. (1996) Growth regulation by peroxisome proliferators: opposing activities in early and late G1. Cancer Res., 56, 3257-3264.
35. Schreck,R., Reiber,P. and Baeuerle,P.A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of NF-κB transcription factor and HIV-1. EMBO J., 10, 2247-2258.
36. Cressman,D.E., Greenbaum,L.E., Harber,B.A. and Taub,R. (1994) Rapid activation of post-hepatectomy factor/nuclear factor κB in hepatocytes, a primary response in the regenerating liver. J. Biol. Chem., 269, 30429-30435.
37. Li, Y., Leung,L.K., Spear,B.T. and Glauert,H.P. (1996) Activation of hepatic NF-κB by phenobarbital in rats. Biochem. Biophys. Res. Commun., 229, 982-989.
38. Kadonaga,J.T., Carner,K.R., Masiarz,F.R. and Tjian,R. (1987) Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell, 51, 1079-1090.
39. Leggett,R.W., Armstrong,S.A., Barry,D. and Mueller,C.R. (1995) Sp1 is phosphorylated and its DNA-binding activity is down-regulated upon terminal differentiation of the liver. J. Biol. Chem., 270, 25879-25884.
40. 2-generating peroxisomal fatty acyl-CoA oxidase. Proc. Natl Acad. Sci. USA, 92, 7080-7084.
41. 2-generating peroxisomal urate oxidase. Cancer Res., 56, 4846-4852.
42. 2 for platelet-derived growth factor signal transduction. Science, 270, 296-299.
43. Karin,M. (1995) The regulation of AP-1 activity by mitogen-activated protein kinase. J. Biol. Chem., 270, 16483-16486.